Find out how much you know with these random facts and trivia questions on movies, music, history, science, geography and so ...
After Johnson & Johnson last year changed its mind on its 2017 purchase of aprocitentan, the medicine's original maker has ushered the drug across the FDA finish line. The once-daily drug, branded as ...
Idorsia’s plans to sell its hypertension drug Tryvio have faced a speed bump, even as the biotech plows ahead with around 250 layoffs. Last month, the company said it had secured a $35 million ...
With the latest hopes of licensing its hypertension drug Tryvio falling through, Idorsia has moved to claw back $100 million in upcoming development costs from a separate deal with Viatris. Idorsia ...
(RTTNews) - Idorsia Ltd (IDRSF. OB) announced that the US Food & Drug Administration, after having released TRYVIO from its Risk Evaluation and Mitigation Strategy or REMS requirement, has now ...